Rayaldee is now approved! Visit the new Rayaldee Web Site  

Promoting Health through Vitamin D Therapeutics

Improving People's Lives by Treating and Preventing the Clinical Consequences of
Vitamin D Insufficiency and Secondary Hyperparathyroidism


Recent News:

OPKO Health Announces Appointment of Patricia Sandler as National Sales Director for Rayaldee
July 19, 2019

OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients
September 04, 2018

OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada
July 16, 2018




© 2019 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use